These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3164308)

  • 21. Tics and fits. The current status of Gilles de la Tourette syndrome and its relationship with epilepsy.
    Rickards H
    Seizure; 1995 Dec; 4(4):259-66. PubMed ID: 8719917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine in the treatment of Tourette's syndrome exacerbation due to haloperidol withdrawal.
    Max JE; Rasmussen SA
    J Nerv Ment Dis; 1986 Apr; 174(4):243-6. PubMed ID: 3457098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gilles de la Tourette's syndrome. An overview of clinical experience.
    Bruun RD
    J Am Acad Child Psychiatry; 1984 Mar; 23(2):126-33. PubMed ID: 6585414
    [No Abstract]   [Full Text] [Related]  

  • 24. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome.
    Miguel EC; Baer L; Coffey BJ; Rauch SL; Savage CR; O'Sullivan RL; Phillips K; Moretti C; Leckman JF; Jenike MA
    Br J Psychiatry; 1997 Feb; 170():140-5. PubMed ID: 9093502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine ameliorates Gilles de la Tourette syndrome.
    Cohen DJ; Detlor J; Young JG; Shaywitz BA
    Arch Gen Psychiatry; 1980 Dec; 37(12):1350-7. PubMed ID: 6255888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The psychopathological spectrum of Gilles de la Tourette syndrome.
    Cavanna AE; Rickards H
    Neurosci Biobehav Rev; 2013 Jul; 37(6):1008-15. PubMed ID: 23131314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome.
    Como PG; Kurlan R
    Neurology; 1991 Jun; 41(6):872-4. PubMed ID: 2046933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gilles de la Tourette Syndrome, Depression, Depressive Illness, and Correlates in a Child and Adolescent Population.
    Rizzo R; Gulisano M; Martino D; Robertson MM
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):243-249. PubMed ID: 28099039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome.
    Robertson MM; Eapen V
    Clin Neuropharmacol; 1992 Oct; 15(5):408-25. PubMed ID: 1358442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 9p monosomy in a patient with Gilles de la Tourette's syndrome.
    Taylor LD; Krizman DB; Jankovic J; Hayani A; Steuber PC; Greenberg F; Fenwick RG; Caskey CT
    Neurology; 1991 Sep; 41(9):1513-5. PubMed ID: 1679912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.
    Cavanna AE; David K; Orth M; Robertson MM
    Eur J Paediatr Neurol; 2012 Nov; 16(6):605-12. PubMed ID: 22381812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological options for the treatment of Tourette's disorder.
    Jiménez-Jiménez FJ; García-Ruiz PJ
    Drugs; 2001; 61(15):2207-20. PubMed ID: 11772131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetics of obsessive compulsive disorder and Gilles de la Tourette's syndrome.
    Pauls DL
    Psychiatr Clin North Am; 1992 Dec; 15(4):759-66. PubMed ID: 1461793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole in patients with Tourette syndrome.
    Bubl E; Perlov E; Tebartz Van Elst L
    World J Biol Psychiatry; 2006; 7(2):123-5. PubMed ID: 16684686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The psychopathology of Gilles de la Tourette's syndrome. A controlled study.
    Robertson MM; Channon S; Baker J; Flynn D
    Br J Psychiatry; 1993 Jan; 162():114-7. PubMed ID: 8425124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Gilles de la Tourette syndrome: the current status.
    Robertson MM
    Arch Dis Child Educ Pract Ed; 2012 Oct; 97(5):166-75. PubMed ID: 22440810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Gilles de la Tourette's syndrome: eight-year, practice-based experience in a predominantly adult population.
    Mesulam MM; Petersen RC
    Neurology; 1987 Dec; 37(12):1828-33. PubMed ID: 3479704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Control of inner speech and Gilles de la Tourette's syndrome].
    Vercueil L
    Encephale; 2003; 29(5):460-2. PubMed ID: 14615696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuropsychiatry of Gilles de la Tourette syndrome: The état de l'art.
    Cavanna AE
    Rev Neurol (Paris); 2018 Nov; 174(9):621-627. PubMed ID: 30098800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.